KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting

NCT07406633 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

GIST - Gastrointestinal Stromal Tumor
GIST
GIST Metastatic Cancer
Gastro Intestinal Stromal Tumour
Gastrointestinal Tumors

Interventions

DRUG: KQB198
DRUG: Imatinib (Gleevec)

Sponsor

Kumquat Biosciences Inc.